Droperidol: Difference between revisions

(Created page with "==Administration== *Type: antipsychotic *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ===Combative patient=== *10mg IM ==Pediatric...")
 
No edit summary
Line 1: Line 1:
==Administration==
==Administration==
*Type: [[antipsychotic]]
*Type: [[antipsychotic]], [[antiemetics]]
*Dosage Forms:
*Dosage Forms:
*Routes of Administration:
*Routes of Administration: IV/IM
*Common Trade Names:  
*Common Trade Names:  


Line 8: Line 8:
===[[Combative patient]]===
===[[Combative patient]]===
*10mg IM
*10mg IM
===[[Headache]]===
*2.5mg IV or 2.5-5mg IM
===[[Nausea/vomiting]]===
*0.625-2.5mg IV


==Pediatric Dosing==
==Pediatric Dosing==
 
===[[Nausea/vomiting]]===
*2-12yo: 0.015-0.1mg/kg IV/IM


==Special Populations==
==Special Populations==
*[[Drug pregnancy categories|Pregnancy Rating]]:
*[[Drug pregnancy categories|Pregnancy Rating]]: C
*Lactation risk:
*Lactation risk: Infant risk cannot be ruled out
===Renal Dosing===
*Renal dosing: Administer with caution
*Adult:
*Hepatic dosing: Administer with caution
*Pediatric:
===Hepatic Dosing===
*Adult:
*Pediatric:


==Contraindications==
==Contraindications==
*Allergy to class/drug
*Allergy to class/drug
*Known or suspected prolonged QT


==Adverse Reactions==
==Adverse Reactions==
===Serious===
===Serious===
 
*Prolonged QT, torsades, ventricular tachycardia, cardiac arrest
 
**''Note: effect on QT interval is dose-dependent''
*Neuroleptic malignant syndrome
*Anaphylaxis
===Common===
===Common===
 
*Somnolence, dysphoria
*Anxiety, restlessness, hyperactivity
*Hypotension
*Tachycardia


==Pharmacology==
==Pharmacology==
*Half-life:  
*Half-life: 123-147m (adults), 75-127m (children)
*Metabolism:  
*Metabolism: hepatic
*Excretion:  
*Excretion: mostly renal


==Mechanism of Action==
==Mechanism of Action==
 
*Dopamine (D2) antagonist. Some serotonergic, histaminergic, and alpha-adrenergic effect


==Comments==
==Comments==
Line 44: Line 51:


==See Also==
==See Also==
 
*[[Antipsychotics]]
*[[Combative patient]]


==References==
==References==

Revision as of 14:54, 3 April 2017

Administration

Adult Dosing

Combative patient

  • 10mg IM

Headache

  • 2.5mg IV or 2.5-5mg IM

Nausea/vomiting

  • 0.625-2.5mg IV

Pediatric Dosing

Nausea/vomiting

  • 2-12yo: 0.015-0.1mg/kg IV/IM

Special Populations

  • Pregnancy Rating: C
  • Lactation risk: Infant risk cannot be ruled out
  • Renal dosing: Administer with caution
  • Hepatic dosing: Administer with caution

Contraindications

  • Allergy to class/drug
  • Known or suspected prolonged QT

Adverse Reactions

Serious

  • Prolonged QT, torsades, ventricular tachycardia, cardiac arrest
    • Note: effect on QT interval is dose-dependent
  • Neuroleptic malignant syndrome
  • Anaphylaxis

Common

  • Somnolence, dysphoria
  • Anxiety, restlessness, hyperactivity
  • Hypotension
  • Tachycardia

Pharmacology

  • Half-life: 123-147m (adults), 75-127m (children)
  • Metabolism: hepatic
  • Excretion: mostly renal

Mechanism of Action

  • Dopamine (D2) antagonist. Some serotonergic, histaminergic, and alpha-adrenergic effect

Comments

See Also

References